PYXS stock

Pyxis Oncology Inc (PYXS) financials · rev $13.9M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Pyxis Oncology Inc (PYXS) rev $13.9M.

Cached annual income statement
LineFY2025FY2023
Revenue$13.9MN/A
Cost of Revenue$2.39MN/A
Gross Profit$11.5MN/A
Operating Income-$84.4M-$82.2M
Net Income-$79.6M-$73.8M
EPS (Diluted)-$1.28-$1.85
Cached annual balance sheet
LineFY2025FY2024
Total Assets$91.5M$157.2M
Current Assets$72.1M$132.4M
Cash & Equivalents$15.4M$19.5M
PP&E$8.00M$9.90M
Total Liabilities$38.1M$36.4M
Current Liabilities$21.1M$17.7M
Shareholders' Equity$53.4M$120.8M
Retained Earnings-$443.2M-$363.6M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$63.5M-$57.7M
CapEx$9.00K$237.0K
Investing Cash Flow$58.9M$8.15M
Financing Cash Flow$594.0K$59.3M
Net Change in Cash-$4.05M$9.81M
Free Cash Flow-$63.5M-$57.9M
These statements as JSON? API free 100/day

FAQ

What is PYXS P/E and revenue?

Pyxis Oncology Inc (PYXS) rev $13.9M.

What is PYXS revenue?

Pyxis Oncology Inc last cached revenue is $13.9M (FY2025).

Is PYXS profitable?

Pyxis Oncology Inc last cached net income is -$79.6M (FY2025).

What are PYXS total assets?

Pyxis Oncology Inc last cached total assets are $91.5M (FY2025).

What is PYXS free cash flow?

Pyxis Oncology Inc last cached free cash flow is -$63.5M (FY2025).

Not investment advice. Cached statements, not a live tape.